EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 50 / No 3 (September 2018) J Extra Corpor Technol, 50 3 (2018) 170-177 References
Free Access
Issue
J Extra Corpor Technol
Volume 50, Number 3, September 2018
Page(s) 170 - 177
DOI https://doi.org/10.1051/ject/201850170
Published online 15 September 2018
  1. Bhopale GM, Nanda RK Blood coagulation factor VIII: An overview. J Biosci. 2003;28:783–9. [CrossRef] [PubMed] [Google Scholar]
  2. Mazurkiewicz-Pisarek A, Płucienniczak G, Ciach T, et al. The factor VIII protein and its function. Acta Biochim Pol. 2016;63:11–6. [CrossRef] [PubMed] [Google Scholar]
  3. Kulkarni R, Soucie JM Pediatric hemophilia: A review. Semin Thromb Hemost. 2011;37:737–44. [CrossRef] [PubMed] [Google Scholar]
  4. Balkaransingh P, Young G Novel therapies and current clinical progress in hemophilia A. Ther Adv Hematol. 2018;9:49–61. [CrossRef] [PubMed] [Google Scholar]
  5. Odonkor P, Srinivas A, Strauss E, et al. Perioperative coagulation management of a hemophilia a patient during cardiac surgery. Semin Cardiothorac Vasc Anesth. 2017;21:312–20. [CrossRef] [PubMed] [Google Scholar]
  6. Butenas S, Parhami-Seren B, Undas A, et al. The “normal” factor VIII concentration in plasma. Thromb Res. 2010;126:119–23. [CrossRef] [PubMed] [Google Scholar]
  7. Cayla H, Morange PE, Chambost H, et al. Management of cardiovascular disease in haemophilia. Thromb Res. 2013;132:8–14. [CrossRef] [PubMed] [Google Scholar]
  8. Lison S, Spannagl M, Dietrick W Haemophilia A in cardiac operations: A model of reduced thrombin generation. Ann Thorac Surg. 2011;91:1606–8. [CrossRef] [PubMed] [Google Scholar]
  9. Tang M, Wierup P, Terp K, et al. Cardiac surgery in patients with haemophilia. Haemophilia. 2009;15:101–7. [CrossRef] [PubMed] [Google Scholar]
  10. Bhave P, McGiffin D, Shaw J Guide to performing cardiac surgery in patients with hereditary bleeding disorders. J Card Surg. 2015;30:61–9. [CrossRef] [PubMed] [Google Scholar]
  11. Ferraris VA, Boral LI, Cohen AJ, et al. Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. Cardiol Rev. 2015;23:53–68. [CrossRef] [PubMed] [Google Scholar]
  12. McNair E, Marcoux JA, Bally C, et al. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion. 2016;31:189–99. [CrossRef] [PubMed] [Google Scholar]
  13. Misgav M, Mandelbaum T, Kassif Y, et al. Thromboelastography during coronary artery bypass grafting surgery of severe hemophilia A patient—The effect of heparin and protamine on factor VIII activity. Blood Coagul Fibrinolysis. 2017;28:329–33. [CrossRef] [PubMed] [Google Scholar]
  14. Wyeth TM 2016 Xyntha® lyophilized powder for reconstitution. Available at: www.pfizer.ca. Accessed September 20, 2017. [Google Scholar]
  15. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–47. [CrossRef] [PubMed] [Google Scholar]
  16. Nogami K The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 2016;174:503–14. [CrossRef] [PubMed] [Google Scholar]
  17. Chitlur M, Rivard GE, Lillicrap D Recommendations for performing thromboelastography/thromboelastometry in hemophilia: Communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:103–6. [CrossRef] [PubMed] [Google Scholar]
  18. Hazendonk HC, Lock J, Mathôt RA Perioperative treatment of hemophilia A patients: Blood group O patients are at risk of bleeding complications. J Thromb Haemost. 2016;14:468–78. [CrossRef] [PubMed] [Google Scholar]
  19. Chandler WL, Ferrell C, Lee J, et al. Comparison of three methods for measuring factor VIII levels in plasma. Am J Clin Path. 2003;120:34–9. [CrossRef] [PubMed] [Google Scholar]
  20. Newman RS, Fagin AR Heparin contamination in coagulation testing and a protocol to avoid it and the risk of inappropriate FFP transfusion. Am J Clin Pathol. 1995;104:447–9. [CrossRef] [PubMed] [Google Scholar]
  21. Moser KA, Adcock Funk DM Chromogenic factor VIII activity assay. Am J Hematol. 2014;89:781–4. [CrossRef] [PubMed] [Google Scholar]
  22. Karkouti K, McCluskey SA, Syed S, et al. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: A prospective observational study. Anesth Analg. 2010;110:1533–40. [CrossRef] [PubMed] [Google Scholar]
  23. Shi J, Wang G, Hong L, et al. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: Randomized trial and 1-year follow-up. Ann Thorac Surg. 2013;95:795–802. [CrossRef] [PubMed] [Google Scholar]
  24. Tang M, Wierup P, Terp K Cardiac surgery in patients with haemophilia. Haemophilia. 2009;15:101–7. [CrossRef] [PubMed] [Google Scholar]
  25. Chaplin S The use of tranexamic acid in reducing bleeding complications. J Haem Pract. 2016;3:1–9. [Google Scholar]
  26. Patel J, Prajapati M, Patel H, et al. Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery. Asian Cardiovasc Thorac Ann. 2017;25:118–22. [CrossRef] [PubMed] [Google Scholar]
  27. Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study. Anesthesiology. 2011;115:1179–91. [CrossRef] [PubMed] [Google Scholar]
  28. Ortmann E, Rubino A, Altemimi B, et al. Validation of viscoelastic coagulation tests during cardiopulmonary bypass. J Thromb Haemost. 2015;13:1207–16. [CrossRef] [PubMed] [Google Scholar]
  29. Rossi M, Jayaram R, Sayeed R Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes? Interact Cardiovasc Thorac Surg. 2011;13:320–31. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.